Machine learning‐based prediction of bleeding risk in extracorporeal membrane oxygenation patients using transfusion as a surrogate marker

Documenti analoghi

• Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation
  di: Ayda Javanbakht, et al.
  Pubblicazione: (2024)
• Red blood cell transfusion practices in extracorporeal membrane oxygenation: A single‐center study
  di: Shailesh Balasubramanian, et al.
  Pubblicazione: (2025)
• A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding
  di: Filip Burša, et al.
  Pubblicazione: (2024)
• Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change
  di: Evan M. Bloch, et al.
  Pubblicazione: (2025)
• A review and analysis of outcomes in randomized clinical trials of plasma transfusion in patients with bleeding or for the prevention of bleeding: The BEST collaborative study
  di: Torunn O. Apelseth, et al.
  Pubblicazione: (2024)